We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Plant Health Care Plc | LSE:PHC | London | Ordinary Share | GB00B01JC540 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.21 | 5.83% | 3.81 | 3.68 | 3.94 | 3.60 | 3.60 | 3.60 | 47,722 | 16:35:02 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pesticides, Agric Chems, Nec | 11.77M | -9.48M | -0.0278 | -1.29 | 12.3M |
TIDMPHC
RNS Number : 4789A
Plant Health Care PLC
12 September 2018
12 September 2018
PLANT HEALTH CARE plc
("Plant Health Care" or the "Company")
US Announces Harpin <ALPHA><BETA> Product Launch in Corn
Plant Health Care(R) , a leading provider of novel patent-protected biological products to global agriculture markets, is pleased to announce the launch of a Harpin <ALPHA><BETA> product for seed treatment applications to field corn.
Harpin <ALPHA><BETA> has been launched as a seed treatment product for field corn in the US and will be marketed and sold as a mixture product by a leading supplier to the US corn grower.
Harpin <ALPHA><BETA> works by triggering the corn plant's own self defense systems, in a manner similar to vaccinations in humans. The plant responds with improved vigor, healthy growth, heightened defense response and, ultimately, increased yield. Results from 2016-2017 field trials provided over a 5 bushel per acre average yield increase. Being a biological product, Harpin <ALPHA><BETA> has a very favorable human and environmental safety profile.
Chris Richards, Executive Chairman and Interim CEO of Plant Health Care noted: "This is an excellent opportunity for Plant Health Care to gain access to the 90 million acre US corn market with an outstanding partner and we look forward to continued product developments in this space. This is the first of a number of product launches we expect to announce in the next 12-18 months."
For further information, please contact:
Plant Health Care plc
Chris Richards, Executive Chairman and Interim CEO Tel: +1 919 926 1600
Jeffrey Tweedy, Commercial Head, Americas
Liberum Capital - Nomad and Broker
Clayton Bush / Chris Clarke Tel: +44 (0) 20 3100 2000
Arden Partners plc - Joint Broker
John Llewellyn-Lloyd / Dan Gee-Summons Tel: +44 (0) 20 7614 5900
IFC Advisory - Financial PR
Graham Herring / Miles Nolan / Zach Cohen Tel: +44 (0) 20 3934 6633
Company website: www.planthealthcare.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
PRLSFFFUFFASEFU
(END) Dow Jones Newswires
September 12, 2018 02:00 ET (06:00 GMT)
1 Year Plant Health Care Chart |
1 Month Plant Health Care Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions